Lian JF - Search Results

1

Patient compliance and persistence with antihyperglycemic drug regimens: evaluation of a medicaid patient population with type 2 diabetes mellitus.

Dailey G, Kim MS, Lian JF. Dailey G, et al. Among authors: lian jf. Clin Ther. 2001 Aug;23(8):1311-20. doi: 10.1016/s0149-2918(01)80110-7. Clin Ther. 2001. PMID: 11558867

2

Patient compliance and persistence with anti-hyperglycemic therapy: evaluation of a population of type 2 diabetic patients.

Dailey G, Kim MS, Lian JF. Dailey G, et al. Among authors: lian jf. J Int Med Res. 2002 Jan-Feb;30(1):71-9. doi: 10.1177/147323000203000111. J Int Med Res. 2002. PMID: 11921502 Free article.

3

Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population.

Jones JK, Gorkin L, Lian JF, Staffa JA, Fletcher AP. Jones JK, et al. Among authors: lian jf. BMJ. 1995 Jul 29;311(7000):293-5. doi: 10.1136/bmj.311.7000.293. BMJ. 1995. PMID: 7633238 Free PMC article.

4

Comparison of the median effective concentration (EC50) and effect of sevoflurane with or without remifentanil in cesarean section with supreme laryngeal mask under narcotrend monitoring: a randomized trial.

Lian JF, Xu YB, Zheng BY, Shen LY, Liao DY, Zheng C, Lin CL, Huang CB, Luo QC, Guo GQ, Lin XD, Wu JW, Xiao QS. Lian JF, et al. Ann Palliat Med. 2021 Nov;10(11):11578-11586. doi: 10.21037/apm-21-2664. Ann Palliat Med. 2021. PMID: 34872283 Free article. Clinical Trial.

5

Effects of Spironolactone on Hypoxia-Inducible Factor-1α in the Patients Receiving Coronary Artery Bypass Grafting.

Lou YM, Zheng ZL, Xie LY, Lian JF, Shen WJ, Zhou JQ, Shao GF, Hu DX. Lou YM, et al. Among authors: lian jf. J Cardiovasc Pharmacol. 2021 Jul 1;78(1):e101-e104. doi: 10.1097/FJC.0000000000001040. J Cardiovasc Pharmacol. 2021. PMID: 34173801

6

YAP regulates ALDH1A1 expression and stem cell property of bladder cancer cells.

Zhao AY, Dai YJ, Lian JF, Huang Y, Lin JG, Dai YB, Xu TW. Zhao AY, et al. Among authors: lian jf. Onco Targets Ther. 2018 Oct 10;11:6657-6663. doi: 10.2147/OTT.S170858. eCollection 2018. Onco Targets Ther. 2018. PMID: 30349299 Free PMC article.

7

Modification of N-(6-(2-methoxy-3-(4-fluorophenylsulfonamido)pyridin-5-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)acetamide as PI3Ks inhibitor by replacement of the acetamide group with alkylurea.

Wang XM, Mao S, Cao L, Xie XX, Xin MH, Lian JF, Cao YX, Zhang SQ. Wang XM, et al. Among authors: lian jf. Bioorg Med Chem. 2015 Sep 1;23(17):5662-71. doi: 10.1016/j.bmc.2015.07.017. Epub 2015 Jul 17. Bioorg Med Chem. 2015. PMID: 26210161

8

Novel piperazinediones as antitumor agents.

Wang CL, Lee O, Hsiao G, Lian JF, Cheng YW. Wang CL, et al. Among authors: lian jf. Anticancer Res. 2014 Aug;34(8):4013-9. Anticancer Res. 2014. PMID: 25075024

9

Azatyrosinamides: novel RAS-related anticancer agents.

Wang CL, Lee O, Huang CF, Li EI, Teng CM, Pan SL, Lian JF, Chang FS, Liou JP, Wang HP. Wang CL, et al. Among authors: lian jf. Anticancer Res. 2013 Feb;33(2):425-32. Anticancer Res. 2013. PMID: 23393333

10

The total synthesis of a ganglioside Hp-s1 analogue possessing neuritogenic activity by chemoselective activation glycosylation.

Tsai YF, Shih CH, Su YT, Yao CH, Lian JF, Liao CC, Hsia CW, Shui HA, Rani R. Tsai YF, et al. Among authors: lian jf. Org Biomol Chem. 2012 Feb 7;10(5):931-4. doi: 10.1039/c2ob06827c. Epub 2011 Dec 19. Org Biomol Chem. 2012. PMID: 22179062

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page